Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm

Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm

Leslie Citrome,1 Yangchun Du,2 Peter J Weiden3 1Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, USA; 2Biostatistics, Alkermes, Inc., Waltham, MA, USA; 3Medical Affairs, Alkermes, Inc., Waltham, MA, USACorrespondence: Leslie Citrome 11 Medical Park Drive, Suite 106, Pomona...

Full description

Bibliographic Details
Main Authors: Citrome L, Du Y, Weiden PJ
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
aripiprazole lauroxil
long-acting injectable
psychotic disorders
antipsychotic agents
number needed to treat
effect size
Online Access:https://www.dovepress.com/assessing-effectiveness-of-aripiprazole-lauroxil-vs-placebo-for-the-tr-peer-reviewed-article-NDT

Internet

https://www.dovepress.com/assessing-effectiveness-of-aripiprazole-lauroxil-vs-placebo-for-the-tr-peer-reviewed-article-NDT

Similar Items